CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
Nam Hoon Kim, Dong-Lim Kim, Kyeong Jin Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim
Endocrinol Metab. 2017;32(2):241-247.   Published online June 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.241

Excel Download

Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
Endocrinology and Metabolism. 2017;32(2):241   Crossref logo
Link1 Link2 Link3

A 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy
Diabetology & Metabolic Syndrome. 2015;7(1):   Crossref logo
Link1 Link2 Link3 Link4

Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin
Diabetes, Obesity and Metabolism. 2009;11(6):589-595   Crossref logo
Link1 Link2

Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study
International Journal of Endocrinology. 2015;2015:1-5   Crossref logo
Link1 Link2 Link3

Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study
Current Therapeutic Research. 2008;69(4):364-377   Crossref logo
Link1 Link2

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
Diabetes, Obesity and Metabolism. 2009;11(2):157-166   Crossref logo
Link1 Link2

Abstract #805111: Effects of Hydroxychloroquine 400 MG or Teneligliptin 20 MG on Glycemic Variability In Patients with Type 2 Diabetes Inadequately Controlledwith Insulin Plus Oral Therapy: A 12-Week, Randomised Pilot Study
Endocrine Practice. 2020;26:116   Crossref logo
Link1 Link2

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
Journal of Diabetes Investigation. 2018;10(3):714-722   Crossref logo
Link1 Link2 Link3 Link4

Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison
Clinical Therapeutics. 2011;33(12):1932-1942   Crossref logo
Link1 Link2

Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial
Diabetes, Obesity and Metabolism. 2009;11(8):804-812   Crossref logo
Link1 Link2